Author: Nguyen Xuan Thanh MD, PhD et al
Publication Source: JTO
Country: Canada
Date: July 01 2022
Summary of Content: The expensive modern therapeutic regimens for advanced lung cancer stages have been recently approved. This study evaluated whether low-dose computed tomography (LDCT) screening of people in Alberta with a higher risk of developing lung cancer is cost saving.
Link to Document:
https://www.jtocrr.org/article/S2666-3643(22)00074-1/fulltext?dgcid=raven_jbs_etoc_email
